- Home
- » Tags
- » Levonantradol
Top View
- Que Tempolate
- 205525Orig1s000
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Synthetic Cannabinoids in Herbal Products Background
- Behavioral Effects of Levonantradol and Nantradol in the Rhesus Monkey
- Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands
- Marijuana and Health. Report of a Study by a Committee of the Institute of Medicine, Division of Health Sciences Policy
- Future of Cannabis and Cannabinoids in Therapeutics
- (12) Patent Application Publication (10) Pub. No.: US 2005/0266061 A1 Stinchcomb Et Al
- Thesis Rests with Its Author
- Redalyc.Spice Drugs: Los Cannabinoides Como Nuevas
- The Effects of Levonantradol on Rewarding Brain Stimulation Thresholds in the Rat
- Cannabinoids: from Pot to Lab Esther Papaseit1,2, Clara Pérez-Mañá1,2, Ana Pilar Pérez-Acevedo1,2, Olga Hladun1,2, M
- S A. by 222 :-N
- REPORT (MISC. 110110) June 9, 2010 BY: GENERAL
- ... If You Have Issues Viewing Or Accessing This File Contact Us At
- Pyrolytic Fate of Synthetic Cannabinoids
- Cannabinoid Receptor Localization in Brain (Tetrahydrocannabinol/Autoradiography/Basal Ganglla/Hippocampus/Cerebeilum) MILES HERKENHAM*T, ALLISON B
- Systematic Review of Systematic Reviews on Medical Cannabinoids for Pain, Nausea/Vomiting, Spasticity, and Harms: Appendix
- Cannabinoids in Medicine: a Review of Their Therapeutic Potential
- Classical and Nonclassical Cannabinoids: Mechanism of Action-Brain Binding Delta-9-THC Nabilonc Alljn C
- Uhm Phd 9615565 R.Pdf
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Suppression of Noxious Stimulus
- Clinical Pharmacodynamics of Cannabinoids
- (12) United States Patent (10) Patent No.: US 9.623,000 B2 Kindler Et Al
- Chapter 12 (Controlled Substances Act Rules) of Subtitle B (Public Health & Medicine) of Title 22 (Health) of the District of Columbia Municipal Regulations (DCMR)
- And Synthetic-Cannabinoids and the Cannabinoid-Induced Hyperemesis
- Medical Cannabis Evidence on Efficacy
- Medicinal Chemistry of Cannabinoids
- And Reward Systems MILES HERKENHAM Sectrim on Fututional Neuraana~Y National Institutzr of Mend Hmlth Bui~Iiiqg36, Room 20-15 &The&, Matyhnd 20892
- ACMD Report on the Major Cannabinoid Agonists ACMD Advisory Council on the Misuse of Drugs
- Medicinal Cannabis for the Prevention Or Management of Nausea and Vomiting in Australia
- Redalyc.Therapeutic Properties of Cannabinoid Drugs and Marijuana